This inventor holds 1 USPTO granted patent. Top assignee: Joslin Diabetes Center, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Allison B. Goldine
Introduction
Allison B. Goldine is a notable inventor based in Wayland, MA (US). She has made significant strides in the field of diabetes research, particularly in improving glycemic control. Her work is essential for advancing treatment options for individuals with insulin sensitivity issues.
Latest Patents
Allison holds a patent titled "Inhibiting serum response factor (SRF) to improve glycemic control." This patent describes methods for enhancing glycemic control and improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity. Additionally, it outlines methods for identifying new compounds that can be utilized in these treatment methods. She has 1 patent to her name.
Career Highlights
Allison is affiliated with the Joslin Diabetes Center, Inc., where she contributes her expertise to ongoing research and development in diabetes care. Her work at this prestigious institution underscores her commitment to improving the lives of those affected by diabetes.
Collaborations
Throughout her career, Allison has collaborated with esteemed colleagues, including Mary Elizabeth Patti and Wanzhu Jin. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Allison B. Goldine's contributions to diabetes research and her innovative patent demonstrate her dedication to improving health outcomes. Her work continues to inspire advancements in the field of glycemic control.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile